EBOGENES NIPT – Non-Invasive Prenatal Screening

A non-invasive prenatal screening test on the mother's blood that screens for common fetal chromosomal conditions (trisomy 21, 18, 13 and sex chromosome aneuploidies), with optional microdeletions and fetal sex.

What it tests

Fetal chromosomal abnormalities using cell-free fetal DNA (cffDNA), including Trisomy 21 (Down Syndrome), Trisomy 18 (Edwards Syndrome), Trisomy 13 (Patau Syndrome), sex chromosome aneuploidies (e.g., Turner or Klinefelter Syndrome), and fetal sex determination.

How it works

Order online → blood draw at a partner clinic; the clinic ships your sample to the laboratory overnight → laboratory analysis → report delivered as a PDF in your EBOGENES customer portal or by email, with a free AI-assisted consultation on E-AI.ca (general information, not medical advice).

What's in the box

No kit shipped – sample is collected at a clinic

At a glance

• Sample: Maternal blood (blood draw)
• Collection: Clinic / blood-draw site
• Report time: 3–5 business days after the laboratory receives the sample
• Test type: Screening
• Who it is for: Pregnant individuals, in coordination with their prenatal care provider.

Storage & handling

Not applicable – sample collected and handled by the clinic. The clinic ships the blood sample to the laboratory overnight (FedEx).

Laboratory & report

Blood draw: partner clinic. Laboratory analysis: an accredited partner laboratory. Report and interpretation: prepared by the EBOGENES science team and reviewed by a licensed physician. Report: 3–5 business days after the laboratory receives your sample. Your sample is shipped from the clinic to the laboratory overnight.

FAQ

What sample do I provide, and can I do it at home? Maternal blood (blood draw). Collection setting: Clinic / blood-draw site.

How long until I get my report? 3–5 business days after the laboratory receives your sample, plus overnight shipping from the clinic to the laboratory.

Can this test diagnose a disease? A screening test, not a diagnosis. High-risk results must be confirmed by diagnostic testing (e.g. amniocentesis).

What happens to my data? Your genetic data and report are stored in Canada. Samples are destroyed within 30 days after your report is issued, unless you consent to longer storage. You can request deletion at any time by emailing info@ebovir.ca or through your customer portal; we complete requests within 30 days, except for records we must keep by law. We never use your sample or data for research.

A screening test, not a diagnosis. High-risk results must be confirmed by diagnostic testing (e.g. amniocentesis). Screening / information test – not a diagnosis. Discuss results with your healthcare provider

Data stored in Canada (AWS ca-central-1).